Emmanuel Di Valentin, Doctor
" There is no effective antiviral treatment for SARS-Cov-2 which is responsible for the current pandemic. Research efforts are therefore focused on the rapid development of vaccines and the evaluation of antiviral drugs. Testing the effectiveness of these on virus cultures is laborious and requires a BSL3 environment. In order to be able to evaluate (quickly and in safe conditions) the effectiveness of the various drugs acting against this virus, cells expressing Sars-Cov2 viral enzymes will be generated. In these cells, enzymatic activity would be easily quantifiable using a reporter system. In a first phase of our project, different FDA-approuved drugs will be tested, hoping to identify some that will be effective against viral enzymes. "
Funding: FONDATION LEON FREDERICQ
Contact: Dr. Emmanuel Di Valentin Platform manager University of LIEGE (ULiege) Giga Viral Vectors Platform Tour GIGA B34 (+4) CHU Avenue Hypocrate 1 B-4000 LIEGE (Sart Tilman) Tel. +32 (0) 4 366 45...